Home » Newsletters » BioWorld Science

BioWorld Science

July 29, 1998

View Archived Issues

Possible therapeutic strategy for atherosclerosis: interruption of CD40 signaling

Platelet activity after coronary thrombolysis with reteplase and alteplase

SQ-29548 protects against COX inhibitor-associated postischemic cardiac dysfunction

Novel antiasthmatic TYB-2285 reported to inhibit late asthmatic response and histamine release

Rights to rhFIX gene for use in gene therapy available from BTG

Wyeth-Ayerst to market Abelcet in Greece

Ergo Science completes enrollment of phase II Ergoset clinical study for obesity

Texas Biotechnology reports additional positive phase IIa trial results for TBC-11251

Inhibitor of IgE antibody production discovered by Asahi Chemical

Aronex expands clinical development program for Atragen

Gelatinase inhibitors in development by Kotobuki

Bronchodilators with a pyrrolopyrazolopyrimidine structure patented by Pola

Novavax extends option agreement with Cantab

Dainippon claims series with potential for urinary incontinence

Protein farnesyltransferase inhibitors from Kyowa Hakko

Roche: Q2 1998 highlights

Potassium channel-blocking immunosuppressants from Merck & Co.

KRH-594: profile of a new angiotensin II receptor antagonist

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...